INVE.B

282.2

+2.71%↑

INVE.A

282.2

+2.81%↑

HEXA.B

96.06

+3.18%↑

MYCR

202.4

+3.48%↑

BILL

99.4

+1.58%↑

INVE.B

282.2

+2.71%↑

INVE.A

282.2

+2.81%↑

HEXA.B

96.06

+3.18%↑

MYCR

202.4

+3.48%↑

BILL

99.4

+1.58%↑

INVE.B

282.2

+2.71%↑

INVE.A

282.2

+2.81%↑

HEXA.B

96.06

+3.18%↑

MYCR

202.4

+3.48%↑

BILL

99.4

+1.58%↑

INVE.B

282.2

+2.71%↑

INVE.A

282.2

+2.81%↑

HEXA.B

96.06

+3.18%↑

MYCR

202.4

+3.48%↑

BILL

99.4

+1.58%↑

INVE.B

282.2

+2.71%↑

INVE.A

282.2

+2.81%↑

HEXA.B

96.06

+3.18%↑

MYCR

202.4

+3.48%↑

BILL

99.4

+1.58%↑

Search

AddLife AB

Slēgts

188.5 2.84

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

183.1

Max

189.7

Galvenie mērījumi

By Trading Economics

Ienākumi

-31M

119M

Pārdošana

-116M

2.7B

P/E

Sektora vidējais

70.318

98.221

EPS

0.98

Dividenžu ienesīgums

0.42

Peļņas marža

4.404

Darbinieki

2,251

EBITDA

6M

235M

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.42%

2.26%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

2.8B

23B

Iepriekšējā atvēršanas cena

185.66

Iepriekšējā slēgšanas cena

188.5

AddLife AB Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 26. jūn. 23:49 UTC

Peļņas

Nike Sees Sales Decline Decelerating in 1Q as Turnaround Strategy Plays Out -- 2nd Update

2025. g. 26. jūn. 22:19 UTC

Iegādes, apvienošanās, pārņemšana

FTC Clears Alimentation Couche-Tard's $1.57 Billion GetGo Acquisition

2025. g. 26. jūn. 21:30 UTC

Peļņas

Nike 4Q Profit, Revenue Slides as Turnaround Strategy Plays Out -- Update

2025. g. 26. jūn. 21:07 UTC

Peļņas

Nike 4Q Profit, Revenue Slide as Turnaround Strategy Plays Out

2025. g. 26. jūn. 23:49 UTC

Tirgus saruna

Nikkei May Rise as Fears About Middle East Conflict Ebb -- Market Talk

2025. g. 26. jūn. 23:39 UTC

Tirgus saruna

Gold Edges Lower, Weighed by Stronger-Than-Expected U.S. Data -- Market Talk

2025. g. 26. jūn. 23:34 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers: Lease Reset Provides Opportunity for Upgrades, Extensions

2025. g. 26. jūn. 23:33 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers: 62 BWP-Owned Bunnings Sites Get Significantly Longer Leases

2025. g. 26. jūn. 23:32 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers Will No Longer Receive Earnings From BWP Management

2025. g. 26. jūn. 23:32 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers to Increase BWP Holding to 23.5% From 22.3%

2025. g. 26. jūn. 23:31 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers: New BWP Units Priced at 9.2% Premium to Last Close

2025. g. 26. jūn. 23:31 UTC

Iegādes, apvienošanās, pārņemšana

BWP to Pay A$100 Mln Cash, A$42.6 Mln in New Units

2025. g. 26. jūn. 23:30 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers' Bunnings, BWP Trust to Extend and Vary Leases

2025. g. 26. jūn. 23:29 UTC

Iegādes, apvienošanās, pārņemšana

Wesfarmers to Sell BWP Management to BWP Trust for A$142.6M

2025. g. 26. jūn. 23:19 UTC

Iegādes, apvienošanās, pārņemšana

Andlauer Healthcare Group: Ontario Superior Court of Justice Issues Final Order Approving Sale to UPS

2025. g. 26. jūn. 22:06 UTC

Peļņas

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

2025. g. 26. jūn. 21:15 UTC

Peļņas

Nike 4Q Profit, Rev Slides as Turnaround Strategy Plays Out -- Update

2025. g. 26. jūn. 21:07 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: 35 Stores to Be Divested in Accordance With Regulatory Requirements >ATD.T

2025. g. 26. jūn. 21:07 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: GetGo Will Operate as Separate, Stand-Alone Business Unit, Maintain myPerks Loyalty Program >ATD.T

2025. g. 26. jūn. 21:07 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: Buyer Will be Approved by the FTC >ATD.T

2025. g. 26. jūn. 21:07 UTC

Peļņas

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

2025. g. 26. jūn. 21:06 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard Agreed to Sell 35 Sites, Including 34 Circle K Locations and One GetGo Property >ATD.T

2025. g. 26. jūn. 21:06 UTC

Iegādes, apvienošanās, pārņemšana

Couche-Tard: Transaction Is Expected to Close in the Coming Days >ATD.T

2025. g. 26. jūn. 21:06 UTC

Tirgus saruna

Bank of Mexico Seen Likely to Slow Pace of Rate Cuts -- Market Talk

2025. g. 26. jūn. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

2025. g. 26. jūn. 21:05 UTC

Iegādes, apvienošanās, pārņemšana

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

2025. g. 26. jūn. 20:52 UTC

Peļņas

Nike 4Q Profit, Rev Slide as Turnaround Strategy Plays Out

2025. g. 26. jūn. 20:51 UTC

Peļņas

Correct: Nike 4Q Net $211M, Not $200M >NKE

2025. g. 26. jūn. 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 26. jūn. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

AddLife AB Prognoze

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.